海森药业：关于签订募集资金专户存储三方监管协议的公告

Group 1 - The core point of the article is that Haishen Pharmaceutical has established a special account for fundraising management to protect investor rights [1] - The company has opened a fundraising special account at the Dongyang branch of the Bank of China [1] - A tripartite supervision agreement has been signed with the bank and the sponsor, CITIC Securities Co., Ltd. [1]